FILTER BY:
Details
A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma
Address: 225 Summit Ave, Montvale, NJ 07645, USA
Phone: 877-451-7009
Mesothelioma Type:
- Pleural: True
- Peritoneal: False
- Pericardial: False
- Tunica Vaginalis: False
Type: Epitheliod, Biphasic, Sarcomatoid
Condition: Malignant Pleural Mesothelioma
Description: The purpose of this study is to find out whether IMPRINT in combination with pembrolizumab is a safe treatment for people with malignant pleural mesothelioma (MPM).The highest dose of IMPRINT that causes few or mild side effects when given in combination with pembrolizumab will be found. Once the highest safe dose of IMPRINT is found, it will be tested in combination with pembrolizumab in future participants to see whether the combination may be an effective treatment for MPM.
Research Center: Memorial Sloan Kettering Bergen
Treatment Interventions: DRUG: Pembrolizumab, RADIATION: IMPRINT
Potential Impact: Low
Clinical Trial Number: NCT04897022
Phase: Phase 1
Status: Recruiting
